000 | 04038cam a2200817Ia 4500 | ||
---|---|---|---|
001 | ocn841170430 | ||
003 | OCoLC | ||
005 | 20171224114259.0 | ||
006 | m o d | ||
007 | cr cn||||||||a | ||
008 | 130403s2013 gw a ob 001 0 eng d | ||
040 |
_aE7B _beng _epn _cE7B _dOCLCQ _dOCLCO _dDG1 _dCUS _dN$T _dYDXCP _dOCLCA _dNOC _dOCLCQ _dOCLCO _dOCLCF _dOCLCQ _dEBLCP _dIDEBK _dCOO _dCDX _dDKDLA |
||
019 |
_a833767002 _a857445483 _a898059839 _a961570576 _a962651666 |
||
020 |
_a9783527670383 _q(electronic bk.) |
||
020 |
_a3527670386 _q(electronic bk.) |
||
020 |
_a9783527670390 _q(electronic bk.) |
||
020 |
_a3527670394 _q(electronic bk.) |
||
020 | _z9783527332557 | ||
020 | _a3527332553 | ||
020 | _a9783527332557 | ||
020 | _a9781299402201 | ||
020 | _a1299402208 | ||
029 | 1 |
_aAU@ _b000051628951 |
|
029 | 1 |
_aCHBIS _b010026926 |
|
029 | 1 |
_aCHVBK _b306240947 |
|
029 | 1 |
_aDEBBG _bBV042795223 |
|
029 | 1 |
_aNZ1 _b15340141 |
|
029 | 1 |
_aDEBBG _bBV043395769 |
|
029 | 1 |
_aAU@ _b000053034676 |
|
029 | 1 |
_aDKDLA _b820120-katalog:000651630 |
|
035 |
_a(OCoLC)841170430 _z(OCoLC)833767002 _z(OCoLC)857445483 _z(OCoLC)898059839 _z(OCoLC)961570576 _z(OCoLC)962651666 |
||
037 |
_a471470 _bMIL |
||
050 | 4 |
_aRC119 _b.T79 2013eb |
|
072 | 7 |
_aMED _x103000 _2bisacsh |
|
082 | 0 | 4 |
_a616.9/6 _223 |
049 | _aMAIN | ||
245 | 0 | 0 |
_aTrypanosomatid diseases : _bmolecular routes to drug discovery / _cedited by Timo Jäger, Oliver Koch, and Leopold Flohé. |
250 | _aFirst edition. | ||
260 |
_aWeinheim : _bWiley-VCH, _c2013. |
||
300 |
_a1 online resource (xxviii, 547 pages) : _billustrations (some color). |
||
336 |
_atext _btxt _2rdacontent |
||
337 |
_acomputer _bc _2rdamedia |
||
338 |
_aonline resource _bcr _2rdacarrier |
||
490 | 1 |
_aDrug discovery in infectious diseases ; _vv. 4 |
|
500 | _aEdition statement from running title area. | ||
504 | _aIncludes bibliographical references and index. | ||
505 | 0 | _apt. 1. Disease burden, current treatments, medical needs, and strategic approaches -- pt. 2. Metabolic peculiarities in the trypanosomatid family guiding drug discovery -- pt. 3. Validation and selection of drug targets in kinetoplasts -- pt. 4. Examples of target-based approaches and compounds under consideration. | |
588 | 0 | _aOnline resource; title from PDF title page (Wiley, viewed May 28, 2013). | |
520 | _aThis is the first resource to provide researchers in academia and industry with an urgently needed update summarizing the current knowledge and possibilities for drug intervention against Trypanosomatides all in one volume. As such, it covers every aspect of the topic from basic research findings, via current treatments to translational approaches in drug development and includes both human and livestock diseases. The outstanding editor and contributor team reads like a Who?s Who of the field, thus guaranteeing the outstanding quality of this ready reference. | ||
650 | 0 | _aParasitic diseases. | |
650 | 0 | _aTrypanosomatidae. | |
650 | 7 |
_aMEDICAL _xParasitology. _2bisacsh |
|
650 | 7 |
_aParasitic diseases. _2fast _0(OCoLC)fst01053151 |
|
650 | 7 |
_aTrypanosomatidae. _2fast _0(OCoLC)fst01158279 |
|
650 | 4 |
_aTrypanosomiasis _xChemotherapy. |
|
650 | 4 | _aTrypanosomiasis. | |
655 | 4 | _aElectronic books. | |
700 | 1 | _aJäger, Timo. | |
700 | 1 | _aKoch, Oliver. | |
700 | 1 |
_aFlohé, L. _q(Leopold), _d1938- |
|
776 | 0 | 8 |
_iPrint version: _tTrypanosomatid diseases. _dWeinheim, Germany : Wiley-Blackwell, [2013] _z9783527332557 _w(OCoLC)843345756 |
830 | 0 |
_aDrug discovery in infectious diseases ; _vv. 4. |
|
856 | 4 | 0 |
_uhttp://onlinelibrary.wiley.com/book/10.1002/9783527670383 _zWiley Online Library |
938 |
_aebrary _bEBRY _nebr10677831 |
||
938 |
_aEBSCOhost _bEBSC _n565737 |
||
938 |
_aYBP Library Services _bYANK _n10381564 |
||
938 |
_aCoutts Information Services _bCOUT _n25154319 |
||
938 |
_aEBL - Ebook Library _bEBLB _nEBL1157730 |
||
938 |
_aIngram Digital eBook Collection _bIDEB _ncis25154319 |
||
994 |
_a92 _bDG1 |
||
999 |
_c12687 _d12687 |